To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
ICG and Goldman back Synerlab €160m refi
The unitranche package opens a capex line and acquisition line for the pharmaceutical company, which is expected to complete two purchases in the next couple of months.
